Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000030

Chief Medical Officer sold 7,641 shares at an average $40.91 ($312,560)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goncalves Joana · Chief Medical Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-16 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $6.84 $23,940 37,518 D
2026-03-16 Exercise or conversion : show line 2 in the form 10b5-1 +3,500 $7.80 $27,300 41,018 D
2026-03-16 Sale : show line 3 in the form 10b5-1 −2,921 $40.11 $117,159 38,097 D
2026-03-16 Sale : show line 4 in the form 10b5-1 −2,902 $41.20 $119,569 35,195 D
2026-03-16 Sale : show line 5 in the form 10b5-1 −1,177 $41.94 $49,359 34,018 D
2026-03-16 Sale : show line 6 in the form 10b5-1 −641 $41.30 $26,473 33,377 D
Open-market sales · 7,641 sh · avg $40.91 · $312,560

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-16 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) −3,500 214,563 D
2026-03-16 Exercise or conversion : show line 8 in the form 10b5-1 Employee Warrant (right to buy) −3,500 185,992 D
Loading xslF345X05/form4.xml…